Tamoxifen inhibits acidification in cells independent of the estrogen receptor

被引:96
作者
Altan, N
Chen, Y
Schindler, M
Simon, SM
机构
[1] Rockefeller Univ, Lab Cellular Biophys, New York, NY 10021 USA
[2] Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA
关键词
pH; multidrug resistance; breast cancer; bone resorption;
D O I
10.1073/pnas.96.8.4432
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tamoxifen has been reported to have numerous physiological effects that are independent of the estrogen receptor, including sensitization of resistant tumor cells to many chemotherapeutic agents. Drug-resistant cells sequester weak base chemotherapeutics in acidic organelles away from their sites of action in the cytosol and nucleus. This work reports that tamoxifen causes redistribution of weak base chemotherapeutics from acidic organelles to the nucleus in drug-resistant cells. Agents that disrupt organelle acidification (e.g., monensin, bafilomycin A(1)) cause a similar redistribution. Measurement of cellular pH in several cell lines reveals that tamoxifen inhibits acidification of endosomes and lysosomes without affecting cytoplasmic pH, Similar to monensin, tamoxifen decreased the rate of vesicular transport though the recycling and secretory pathways. Organellar acidification is required for many cellular functions, and its disruption could account for many of the side effects of tamoxifen.
引用
收藏
页码:4432 / 4437
页数:6
相关论文
共 58 条
  • [1] INHIBITION OF COLLAGENOLYTIC ACTIVITY IN HUMAN LEUKEMIC K562-CELLS BY TAMOXIFEN
    AKELI, MG
    MADOULET, C
    RALLET, A
    JARDILLIER, JC
    [J]. LEUKEMIA RESEARCH, 1991, 15 (12) : 1153 - 1157
  • [2] Defective acidification in human breast tumor cells and implications for chemotherapy
    Altan, N
    Chen, Y
    Schindler, M
    Simon, SM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10) : 1583 - 1598
  • [3] DEFECTIVE ACIDIFICATION OF INTRACELLULAR ORGANELLES IN CYSTIC-FIBROSIS
    BARASCH, J
    KISS, B
    PRINCE, A
    SAIMAN, L
    GRUENERT, D
    ALAWQATI, Q
    [J]. NATURE, 1991, 352 (6330) : 70 - 73
  • [4] INTERACTION OF ANTIESTROGENS WITH BINDING-SITES FOR MUSCARINIC CHOLINERGIC DRUGS AND CALCIUM-CHANNEL BLOCKERS IN CELL-MEMBRANES
    BATRA, S
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (04) : 310 - 312
  • [5] BERGLINDH T, 1980, AM J PHYSIOL, V238, P165
  • [6] BRACKE ME, 1994, CANCER RES, V54, P4607
  • [7] INTERACTION OF TAMOXIFEN WITH THE MULTIDRUG-RESISTANCE P-GLYCOPROTEIN
    CALLAGHAN, R
    HIGGINS, CF
    [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (02) : 294 - 299
  • [8] CIOCCA DR, 1982, CANCER RES, V42, P4256
  • [9] Clarke M, 1998, LANCET, V351, P1451
  • [10] Tamoxifen inhibits the release of arachidonic acid stimulated by thapsigargin in estrogen receptor-negative A549 cells
    Croxtall, JD
    Choudhury, Q
    White, JO
    Flower, RJ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1997, 1349 (03): : 275 - 284